Vicor Q2 revenue rises 26.9% to $143.4 million
Vicor Corporation reported a 26.9% sequential increase in Q2 2026 revenue to $143.4 million, driven by advanced products, with net income reaching $49.8 million. The company forecasts a nearly 10% year-over-year increase in Q3 revenue and over $600 million in revenue for 2026.

*this image is generated using AI for illustrative purposes only.
Vicor Corporation reported Q2 2026 revenue of $143.4 million, a 26.9% increase from Q1 2026, driven by a 45% sequential rise in advanced products revenue. The company recorded a consolidated gross profit margin of 58%, an increase of 280 basis points from the prior quarter, and net income of $49.8 million. GAAP diluted EPS was $1.04, based on a fully diluted share count of 47,708,000 shares. Cash and cash equivalents increased to $453.6 million at the end of Q2, bolstered by a $14.3 million CHIPS Act tax credit refund.
Financial Performance
The company's total operating expenses increased 6.1% sequentially to $48.2 million, attributed partly to contingent legal expenses associated with a new license agreement. Vicor recorded a tax benefit of approximately $10.9 million for the quarter, resulting in an effective tax rate of -27.9%. Accounts receivable totaled $78.9 million at quarter end, with days sales outstanding at 37 days. Inventories increased 10.2% sequentially to $104.5 million.
Key Metrics
| Metric | Q2 2026 Value | Sequential Change |
|---|---|---|
| Revenue | $143.4 million | +26.9% |
| Advanced Products Revenue | $94.2 million | +45.0% |
| Gross Profit Margin | 58% | +280 bps |
| Net Income | $49.8 million | N/A |
| GAAP Diluted EPS | $1.04 | N/A |
| Cash and Equivalents | $453.6 million | +$49.4 million |
Operational Highlights
A new licensing agreement contributed $15 million to Q2 revenue. The agreement provides for four $5 million quarterly payments in the first year and $10 million quarterly payments in the second year. Vicor expects this agreement to contribute $5 million in Q3 and $10 million per quarter for the following four quarters. Book-to-bill for the quarter was above one, with a one-year backlog increasing 26% sequentially to $379.7 million.
Outlook
Management expects Q3 revenue to increase nearly 10% year over year. The company anticipates over $600 million in revenue for 2026 and is planning for double-digit sequential increases in product revenue for advanced products. Vicor is also pursuing a second chip fab to support long-term growth, with financial objectives targeting $2.5 billion in revenue at 70% gross margins.
What is the expected timeline for securing and operationalizing the second chip fab to support the $2.5 billion revenue goal?
How will the company manage the sequential decline in licensing revenue in Q3 relative to Q2?
What specific end markets are driving the 45% sequential increase in advanced products revenue?




























